Gene Silencing May Be Next Big Thing for Amyloidosis

Los Angeles—An innovative new treatment that uses a natural process of gene silencing (RNA interference [RNAi]) has been shown to be highly effective in the treatment of patients with hereditary ATTR (hATTR) amyloidosis with polyneuropathy, a degenerative disorder that affects 50,000 people worldwide.